NCT07232875
- Conditions
- KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting
- Locations
-
- Renji Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
Clinical trial condition
KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting
Explore clinical trials studying KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study